ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 22, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

October 4, 2019

Conditions
Advanced Solid Tumors
Interventions
DRUG

ACY-241

Trial Locations (6)

30322

Remove - Emory University Winship Cancer Institute, Atlanta

78229

CTRC at The UT Health Science Center at San Antonio, San Antonio

85258

Pinnacle Oncology Hematology, Scottsdale

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY